{"id":"W2764071025","doi":"10.1111/apt.14368","title":"Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":276,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Bible College","funders":"Gastroenterological Society of Australia; AbbVie; Takeda Pharmaceuticals U.S.A.; Pfizer","keywords":"Medicine; Therapeutic drug monitoring; Infliximab; Adalimumab; Inflammatory bowel disease; Intensive care medicine; Dosing; Drug; Biosimilar; Disease; Internal medicine; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02019316,0.001934967,0.003402077,0.006581667,0.001097242,0.004152298,0.003546812,0.00814381,0.008397311],"category_scores_gemma":[0.06536726,0.0006440578,0.00256832,0.00730975,0.001841314,0.004590842,0.003413928,0.004913582,0.002863648],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004168279,"about_ca_system_score_gemma":0.01513467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002337716,"about_ca_topic_score_gemma":0.002195945,"domain_scores_codex":[0.9752401,0.01104314,0.005748294,0.001269514,0.005989674,0.0007093644],"domain_scores_gemma":[0.9453314,0.02995119,0.008958089,0.0007983957,0.01326763,0.001693299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001601043,0.00009031231,0.0002713219,0.1160971,0.0002432482,0.0002720349,0.0008354823,0.0008933074,0.0003918081,0.007838408,0.3375704,0.5353366],"study_design_scores_gemma":[0.0001137568,0.0001100481,0.001109525,0.1568262,0.0003562362,0.001035974,0.0006514615,0.0002675416,0.0002315351,0.007640507,0.8315846,0.00007259574],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003760255,0.9255121,0.00216893,0.03861496,0.02743673,0.0002971166,0.0003433693,0.0000440432,0.005206824],"genre_scores_gemma":[0.006544933,0.9598299,0.00482606,0.0148905,0.01037348,0.0004945973,0.0007407768,0.00002874909,0.002271006],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02019316,"threshold_uncertainty_score":0.1067929,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07897866906373673,"score_gpt":0.4131626218953791,"score_spread":0.3341839528316424,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}